Q2 2024 Regenxbio Inc Earnings Call Transcript
Welcome everyone to the Q2 2024 Regenxbio earnings conference call. (Operator Instructions)
At this time, I'd like to the conference over to Patrick Christmas, Chief Legal Officer of Regenxbio. Please go ahead.
Good afternoon, and thank you for joining us today. Earlier this afternoon. Regeneron bio released financial and operating results for the second quarter ended June 30th, 2020. For the press release is available on our website at www.regenxbio.com.
Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. It can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend and other words of similar meaning any such forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |